by Discovery | Mar 9, 2022 | Uncategorized
Elizabeth R. Sharlow, Professor of Research, Pharmacology in University of Virginia’s School of Medicine discusses UVA’s Fiske Drug Discovery Laboratory where impactful pharmacological research occurs every day. UVA graduate and undergraduate students are...
by Discovery | Feb 18, 2022 | Featured Collaboration
Charlottesville, Virginia – February 2022 KeViRx, Inc. (“KeViRx”) has been selected to join Blue Knight, a joint initiative between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA), a component of...
by Discovery | Jan 6, 2022 | Grants
Umesh Desai, VaDDC executive committee member and chair of Virginia Commonwealth University’s medicinal chemistry department, has just received an R61/33 grant to develop allosteric inhibitors of coagulation factor XIa. The grant, titled “Lead...
by Discovery | Oct 1, 2021 | Uncategorized
KeViRx is an early stage drug discovery company spun out of the UVA Department of Pharmacology by Elizabeth Sharlow and John Lazo and is located in Charlottesville. KeViRx was just awarded its second National Institutes of Health R43 Phase 1 Small Business Innovation...
by Discovery | Sep 1, 2021 | Uncategorized
Paul Carlier, a professor in the Department of Chemistry in the Virginia Tech College of Science and director of the Virginia Tech Center for Drug Discovery, and his colleagues received a $3.7 million grant from the National Institutes of Health to begin further...
